Skip to main content

Table 3 Adjusted relative risks for Death and Loss to Follow up during TB treatment compared to favorable TB treatment outcomes

From: Is distance associated with tuberculosis treatment outcomes? A retrospective cohort study in Kampala, Uganda

 

Death

Lost to Follow Up

Adjusted RR (95% CI)

Adjusted RR (95% CI)

Euclidean Distance

  < 2 km

Reference

Reference

 2 to < 5 km

1.48 (0.99, 2.22)

0.59 (0.38, 0.89)

 5 to < 10 km

1.38 (0.90, 2.12)

0.61 (0.39, 0.95)

  > 10 km

1.35 (0.86, 2.10)

0.45 (0.25, 0.81)

Age at diagnosis

 0–14 years

0.59 (0.24, 1.46)

0.28 (0.07, 1.12)

 15–24 years

0.59 (0.30, 1.14)

0.80 (0.53, 1.22)

 25–34 years

Reference

Reference

 35–44 years

1.38 (0.94, 2.02)

0.65 (0.42, 0.99)

 45–54 years

1.68 (1.11, 2.54)

0.64 (0.36, 1.12)

 55–64 years

2.08 (1.23, 3.51)

0.51 (0.16, 1.58)

  > 65 years

6.44 (3.69, 11.27)

0.77 (0.20, 3.02)

Male sex

0.98 (0.74, 1.31)

1.31 (0.94, 1.83)

HIV Positive

3.28 (2.23, 4.81)

1.05 (0.73, 1.51)

Pulmonary TB

0.93 (0.66, 1.30)

1.50 (0.78, 2.86)

Lack of bacteriological confirmation

2.14 (1.59, 2.89)

1.45 (0.99, 2.13)

Treatment Start year

 2014

Reference

Reference

 2015

0.78 (0.55, 1.10)

0.88 (0.61, 1.26)

 2016

0.81 (0.59, 1.13)

0.88 (0.61, 1.27)

Facility

 Kisugu Health Center (public)

Reference

Reference

 Alive Medical Services

1.02 (0.63, 1.66)

1.10 (0.74, 1.62)

 International Hospital Kampala

1.41 (0.83, 2.39)

0.60 (0.34, 1.08)

 Kibuli Muslim Hospital

1.48 (0.90, 2.44)

0.83 (0.49, 1.41)

 St. Francis Hospital - Nsambya

0.92 (0.59, 1.45)

0.25 (0.14, 0.46)

 Meeting Point

1.72 (0.51, 5.77)

excluded

  1. Meeting Point reported no patients lost to follow up